Newport Beach, United States
Cartilage Inc., a pioneering entity in the Biotechnology and Health Care sectors, is dedicated to revolutionizing cartilage regeneration with its motto: "Real engineered cartilage for real healing." Founded in 2019, the company is based in the United States and focuses on improving patient quality of life by creating innovative solutions for cartilage defects, particularly in the TMJ disc complex and knee.
Originating from the cutting-edge research at the University of California, Irvine, Cartilage Inc. aims to eliminate the need for repetitive treatments, thereby addressing a significant gap in current healthcare offerings. The company exemplifies potential in not just healing but enhancing the efficacy of long-term patient care.
Their last recorded financial backing, a $256.00K grant in March 2021, was secured from the National Science Foundation, underscoring the technological and practical promise that Cartilage Inc. holds in its field. The startup stands at a promising intersection of medical need and scientific advancement, signaling a robust opportunity for investors eyeing growth in health innovation.
